SFI
VRDN icon

Susquehanna Fundamental Investments’s Viridian Therapeutics VRDN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-101,083
Closed -$3.15M – 693
2025
Q4 		$3.15M Hold
101,083
– – 0.11% 191
2025
Q3 		$2.18M Sell
101,083
-10,462
-9% -$189K 0.09% 225
2025
Q2 		$1.56M Sell
111,545
-65,621
-37% -$891K 0.04% 382
2025
Q1 		$2.39M Buy
+177,166
New +$3.02M 0.04% 481
2023
Q2 		– Sell
-22,777
Closed -$579K – 885
2023
Q1 		$579K Hold
22,777
– – 0.01% 644
2022
Q4 		$665K Buy
22,777
+2,540
+13% +$58.5K 0.01% 773
2022
Q3 		$415K Buy
+20,237
New +$364K 0.01% 1070

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return